[Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004723:Endorphins / Q000502:physiology / Q000627:therapeutic use; D004745:Enkephalins / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000502:physiology* / Q000627:therapeutic use; D010907:Pituitary Hormones / Q000378:metabolism; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000209:etiology / Q000503:physiopathology; D014667:Vasopressins / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D004723:Endorphins; D004745:Enkephalins; D009419:Nerve Tissue Proteins; D010907:Pituitary Hormones; D011619:Psychotropic Drugs; D014667:Vasopressins; D009270:Naloxone; D009271:Naltrexone
Rol' neĭropeptidov v étiologii, patogeneze i klinike psikhicheskikh zabolevaniĭ.